Why distributing a coronavirus vaccine could be "chaos"
The ultra-cold storage requirement for the vaccines will make it challenging for states to get it to their residents, one expert said.
Pfizer
FDA approves remdesivir as COVID treatment
The Food and Drug Administration approved the antiviral drug remdesivir to treat adults who are hospitalized with COVID-19, although it has not been proven to reduce deaths. Dr. Bob Lahita joins CBSN to discuss that plus the latest developments in the race for a vaccine as coronavirus cases spike around the world.
Logistical hurdles in vaccine distribution
The number of confirmed coronavirus cases across the world has surpassed 40 million, as scientists continue to work on developing vaccines. Emergency care physician Dr. Ron Elfenbein, joined CBSN to discuss what hurdles the U.S. and other countries will face in the process to distribute the urgently needed vaccine.
Pfizer won't seek vaccine authorization before election
Pfizer announced Friday it will apply for FDA emergency use authorization for its COVID-19 vaccine "soon after the safety milestone is achieved in the third week in November." Meg Oliver has details.
Pfizer says COVID-19 vaccine could be ready by late November
Drugmaker won't have enough data on its vaccine's safety and efficacy until after presidential election.
Johnson & Johnson starts trial of one-dose COVID-19 vaccine
Phase 3 test launching Wednesday will be one of the world's biggest vaccine studies, with 60,000 volunteers.
ICYMI: Top takeaways from this week's "Face the Nation"
This week we sat down with Pfizer CEO Albert Bourla and former FDA Commissioner Dr. Scott Gottlieb.
Pfizer CEO says company will know if vaccine works by end of October
Approval of a vaccine, however, will depend on federal regulators, Albert Bourla said.
Transcript: Pfizer CEO Albert Bourla on "Face the Nation"
The following is a transcript of an interview with Pfizer CEO Dr. Albert Bourla that aired Sunday, September 13, 2020, on "Face the Nation."
Pfizer CEO says company will know if vaccine works by end of October
Albert Bourla says the drugmaker has manufactured hundreds of thousands of doses.
Pfizer expects COVID-19 vaccine trial results by October
The pharmaceutical company Pfizer said it should know by the end of October whether its vaccine works. Carter Evans has details.
Exxon Mobil dropped from the Dow after nearly a century
It's being replaced by enterprise software company Salesforce.com in another sign of how much the economy has changed.
The race for a coronavirus vaccine
Several companies are well into Phase 3 of their COVID-19 vaccine trials here in the U.S. Dr. Bob Lahita joins CBSN to discuss their progress, plus whether the coronavirus can be detected in America's wastewater.
Inside the "very cautious" U.S. human trial of a COVID vaccine
A doctor on Pfizer's vaccine safety board says the experimental drug causes only minor reactions, but people are "probably going to need two doses."
Final clinical trials on COVID-19 vaccines
Moderna and Pfizer are the first companies to enter Phase 3 clinical testing on a COVID-19 vaccine in the U.S. Each company plans to blind test 30,000 volunteers in hopes of having results and possibly effective vaccines by the end of the year. Meg Oliver reports.
Pfizer to provide U.S. with 100 million COVID-19 vaccine doses
U.S. government will pay pharmaceutical firms almost $2 billion, with a pledge to provide the vaccines for free.
2020 is three days old and drug prices are already jumping
Big Pharma this week jacked up the cost of more than 400 drugs, including these widely used medications.
7 popular drugs may not warrant their price hikes, study says
A watchdog group is questioning whether drugmakers offer significant benefits in exchange for higher prices
Pfizer buying Mylan to create generic drug giant
Pfizer will split off its Upjohn unit, which makes Lipitor, to create a business with at least $19 billion in sales
FDA approves first generic copies of nerve pain drug Lyrica
The pricey pill is pharmaceutical giant Pfizer's no. 2 seller, with sales last year totaling $4.6 billion
Generic drug makers accused of price fixing
More than 40 states say the biggest drug makers engaged in "industry-wide conspiracy" to fix prices of generic drugs
60 Minutes reports: prescription drug price fixing
This week the broadcast reports on a lawsuit claiming drug makers colluded for profit. Last May, it reported one city's fight against high drug prices
Generic drug makers accused of price fixing
Some of the biggest generic drug makers in the industry are being sued for what the attorney general of Connecticut calls an industry-wide conspiracy to fix the prices of generic drugs. Sunday on 60 Minutes
Senators grill pharma executives over rising drug prices
On average, Americans spent $1,162 per person on prescription drugs
Drugmaker behind ibuprofen recall has history of FDA violations
Federal watchdog previously found significant violations of manufacturing rules by Tris Pharma
These factors could decide Netanyahu's fate in Israel's election
First on CBS
Trump's oil and gas stocks gained millions during Iran war
Investigation
Betting companies cap winners while lavishing losers with rewards
Maurene Comey, James Comey's daughter, was unlawfully fired, judge rules
Live
Iran shrugs off Trump's attack threats, says diplomacy ongoing
Duchess Meghan confronted dad over child abuse claims last year
Walter Koenig, actor who played Chekov on "Star Trek," dies at 90
Is the Federal Reserve likely to raise interest rates this week?
